Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies

Go back to Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies
Danaher Corp. (NYSE: DHR) Delayed: 199.05 +3.07 (1.57%)
Previous Close $195.98    52 Week High $102.79 
Open $197.58    52 Week Low $75.71 
Day High $199.84    P/E 52.38 
Day Low $195.05    EPS $3.80 
Volume 3,847,653